Fundraising FoxFerroKin Biosciences
acquired by ShireSan Carlos, US · Founded 2007 · 3 known investors
Find your way into FerroKin Biosciences
Sign up to see every warm intro you have to FerroKin Biosciences
- Paths you didn't know you had: your email and LinkedIn already hold routes to the FerroKin Biosciences team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Developed a next-generation iron chelator for iron overload in transfusion-dependent anemia; acquired by Shire in 2012.
Founders & leadership
FerroKin Biosciences was founded in 2007 by Hugh Y. Rienhoff, Jr., M.D..
HY
Hugh Y. Rienhoff, Jr., M.D.Founder · Chief Executive Officer2006–2012Dr. Rienhoff holds a background in medicine, mathematics, and genetics, and has founded or led multiple biotech companies including FerroKin BioSciences, Imago BioSciences, and Aluco BioSciences. His work translating scientific research into therapeutics has been informed by personal experience identifying a novel genetic syndrome.
Board
Investors · 3
HealthCaplisted by HealthCapStockholm
How we know: HealthCap's portfolio page · a partner's Signal profile · Not right? Tell us
MC Healthcare Ventureslisted by MC Healthcare VenturesCambridge
How we know: MC Healthcare Ventures's portfolio page · Not right? Tell us
Clarus VenturesreportedMenlo Park
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$3M disclosed across 1 round · 2012
▶$3MraisedFeb 2012 · 6 investors · BiotechnologyRule 506(b)
▶$3MraisedFeb 2012 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Marten SteenDirector
- Hugh Y. Rienhoff, Jr., M.D.Executive Officer, Director
- Dennis Henner, Ph.D.Director
- Bryant E. FongDirector
- Offering amount
- $6M
- Amount sold
- $3M
- Minimum investment
- $1
- First sale
- Feb 2012
- Incorporated
- Corporation, Delaware, 2007
- Federal exemptions
- 06
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does FerroKin Biosciences do?
- Developed a next-generation iron chelator for iron overload in transfusion-dependent anemia; acquired by Shire in 2012.
- Who founded FerroKin Biosciences?
- FerroKin Biosciences was founded by Hugh Y. Rienhoff, Jr., M.D. in 2007.
- Who are FerroKin Biosciences's investors?
- FerroKin Biosciences's investors include HealthCap, MC Healthcare Ventures, Clarus Ventures.
- How much funding has FerroKin Biosciences raised?
- FerroKin Biosciences has disclosed $3M raised across 1 round.
- Who acquired FerroKin Biosciences?
- FerroKin Biosciences was acquired by Shire.
- Where is FerroKin Biosciences headquartered?
- FerroKin Biosciences is headquartered in San Carlos, US.